{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:38:39Z","timestamp":1792787919455,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,6,12]],"date-time":"2013-06-12T00:00:00Z","timestamp":1370995200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,6,12]],"date-time":"2013-06-12T00:00:00Z","timestamp":1370995200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1038\/pr.2013.96","type":"journal-article","created":{"date-parts":[[2013,6,12]],"date-time":"2013-06-12T18:19:02Z","timestamp":1371061142000},"page":"266-271","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Mouse model of mevalonate kinase deficiency: comparison of cytokine and chemokine profile with that of human patients"],"prefix":"10.1038","volume":"74","author":[{"given":"Annalisa","family":"Marcuzzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Zanin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Kleiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Monasta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Crovella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,6,12]]},"reference":[{"key":"BFpr201396_CR1","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/343425a0","volume":"343","author":"JL Goldstein","year":"1990","unstructured":"Goldstein JL, Brown MS . Regulation of the mevalonate pathway. Nature 1990;343:425\u201330.","journal-title":"Nature"},{"key":"BFpr201396_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj1990001","volume":"199","author":"R Fears","year":"1981","unstructured":"Fears R . The contribution of the cholesterol biosynthetic pathway to intermediary metabolism and cell function. Biochem J 1981;199:1\u20137.","journal-title":"Biochem J"},{"key":"BFpr201396_CR3","doi-asserted-by":"crossref","first-page":"400","DOI":"10.4049\/jimmunol.157.1.400","volume":"157","author":"JP Drenth","year":"1996","unstructured":"Drenth JP, van der Meer JW, Kushner I . Unstimulated peripheral blood mononuclear cells from patients with the hyper-IgD syndrome produce cytokines capable of potent induction of C-reactive protein and serum amyloid A in Hep3B cells. J Immunol 1996;157:400\u20134.","journal-title":"J Immunol"},{"key":"BFpr201396_CR4","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1002\/art.10550","volume":"46","author":"J Frenkel","year":"2002","unstructured":"Frenkel J, Rijkers GT, Mandey SH, et al. Lack of isoprenoid products raises ex vivo interleukin-1beta secretion in hyperimmunoglobulinemia D and periodic fever syndrome. Arthritis Rheum 2002;46:2794\u2013803.","journal-title":"Arthritis Rheum"},{"key":"BFpr201396_CR5","doi-asserted-by":"publisher","first-page":"3690","DOI":"10.1002\/art.22194","volume":"54","author":"SH Mandey","year":"2006","unstructured":"Mandey SH, Kuijk LM, Frenkel J, Waterham HR . A role for geranylgeranylation in interleukin-1\u03b2 secretion. Arthritis Rheum 2006;54:3690\u20135.","journal-title":"Arthritis Rheum"},{"key":"BFpr201396_CR6","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1016\/j.molimm.2007.12.008","volume":"45","author":"LM Kuijk","year":"2008","unstructured":"Kuijk LM, Mandey SH, Schellens I, et al. Statin synergizes with LPS to induce IL-1\u03b2 release by THP-1 cells through activation of caspase-1. Mol Immunol 2008;45:2158\u201365.","journal-title":"Mol Immunol"},{"key":"BFpr201396_CR7","first-page":"1221","volume":"298","author":"JP Drenth","year":"2001","unstructured":"Drenth JP, Vonk AG, Simon A, Powell R, van der Meer JW . Limited efficacy of thalidomide in the treatment of febrile attacks of the hyper-IgD and periodic fever syndrome: a randomized, double-blind, placebo-controlled trial. J Pharmacol Exp Ther 2001;298:1221\u20136.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFpr201396_CR8","first-page":"260","volume":"63","author":"EJ Bodar","year":"2005","unstructured":"Bodar EJ, van der Hilst JC, Drenth JP, van der Meer JW, Simon A . Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: introducing a vaccination provocation model. Neth J Med 2005;63:260\u20134.","journal-title":"Neth J Med"},{"key":"BFpr201396_CR9","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1203\/PDR.0b013e3181761870","volume":"64","author":"A Marcuzzi","year":"2008","unstructured":"Marcuzzi A, Pontillo A, De Leo L, et al. Natural isoprenoids are able to reduce inflammation in a mouse model of mevalonate kinase deficiency. Pediatr Res 2008;64:177\u201382.","journal-title":"Pediatr Res"},{"key":"BFpr201396_CR10","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.intimp.2010.03.008","volume":"10","author":"A Marcuzzi","year":"2010","unstructured":"Marcuzzi A, Tommasini A, Crovella S, Pontillo A . Natural isoprenoids inhibit LPS-induced-production of cytokines and nitric oxide in aminobisphosphonate-treated monocytes. Int Immunopharmacol 2010;10:639\u201342.","journal-title":"Int Immunopharmacol"},{"key":"BFpr201396_CR11","first-page":"87","volume":"25","author":"A Marcuzzi","year":"2011","unstructured":"Marcuzzi A, Crovella S, Pontillo A . Geraniol rescues inflammation in cellular and animal models of mevalonate kinase deficiency. In Vivo 2011;25:87\u201392.","journal-title":"In Vivo"},{"key":"BFpr201396_CR12","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1203\/PDR.0b013e31821b581c","volume":"70","author":"A Marcuzzi","year":"2011","unstructured":"Marcuzzi A, De Leo L, Decorti G, Crovella S, Tommasini A, Pontillo A . The farnesyltransferase inhibitors tipifarnib and lonafarnib inhibit cytokines secretion in a cellular model of mevalonate kinase deficiency. Pediatr Res 2011;70:78\u201382.","journal-title":"Pediatr Res"},{"key":"BFpr201396_CR13","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.phrs.2010.02.012","volume":"61","author":"L De Leo","year":"2010","unstructured":"De Leo L, Marcuzzi A, Decorti G, Tommasini A, Crovella S, Pontillo A . Targeting farnesyl-transferase as a novel therapeutic strategy for mevalonate kinase deficiency: in vitro and in vivo approaches. Pharmacol Res 2010;61:506\u201310.","journal-title":"Pharmacol Res"},{"key":"BFpr201396_CR14","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/j.1742-7843.2005.pto_138.x","volume":"97","author":"Z Yu","year":"2005","unstructured":"Yu Z, Funayama H, Deng X, et al. Comparative appraisal of clodronate, aspirin and dexamethasone as agents reducing alendronate-induced inflammation in a murine model. Basic Clin Pharmacol Toxicol 2005;97:222\u20139.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"BFpr201396_CR15","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1182\/blood.V85.12.3586.bloodjournal85123586","volume":"85","author":"JP Drenth","year":"1995","unstructured":"Drenth JP, van Deuren M, van der Ven-Jongekrijg J, Schalkwijk CG, van der Meer JW . Cytokine activation during attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Blood 1995;85:3586\u201393.","journal-title":"Blood"},{"key":"BFpr201396_CR16","first-page":"333","volume":"8","author":"P Chomarat","year":"1997","unstructured":"Chomarat P, Banchereau J . An update on interleukin-4 and its receptor. Eur Cytokine Netw 1997;8:333\u201344.","journal-title":"Eur Cytokine Netw"},{"key":"BFpr201396_CR17","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1093\/infdis\/138.6.760","volume":"138","author":"CA Dinarello","year":"1978","unstructured":"Dinarello CA, Elin RJ, Chedid L, Wolff SM . The pyrogenicity of the synthetic adjuvant muramyl dipeptide and two structural analogues. J Infect Dis 1978;138:760\u20137.","journal-title":"J Infect Dis"},{"key":"BFpr201396_CR18","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.tox.2011.08.020","volume":"290","author":"ST Ahmad","year":"2011","unstructured":"Ahmad ST, Arjumand W, Seth A, et al. Preclinical renal cancer chemopreventive efficacy of geraniol by modulation of multiple molecular pathways. Toxicology 2011;290:69\u201381.","journal-title":"Toxicology"},{"key":"BFpr201396_CR19","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1093\/carcin\/bgi291","volume":"27","author":"TP Ong","year":"2006","unstructured":"Ong TP, Heidor R, de Conti A, Dagli ML, Moreno FS . Farnesol and geraniol chemopreventive activities during the initial phases of hepatocarcinogenesis involve similar actions on cell proliferation and DNA damage, but distinct actions on apoptosis, plasma cholesterol and HMGCoA reductase. Carcinogenesis 2006;27:1194\u2013203.","journal-title":"Carcinogenesis"},{"key":"BFpr201396_CR20","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/sj.ejhg.5200614","volume":"9","author":"L Cuisset","year":"2001","unstructured":"Cuisset L, Drenth JP, Simon A, et al.; International Hyper-IgD Study Group. Molecular analysis of MVK mutations and enzymatic activity in hyper-IgD and periodic fever syndrome. Eur J Hum Genet 2001;9:260\u20136.","journal-title":"Eur J Hum Genet"},{"key":"BFpr201396_CR21","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/sj.ejhg.5200595","volume":"9","author":"SM Houten","year":"2001","unstructured":"Houten SM, Koster J, Romeijn GJ, et al. Organization of the mevalonate kinase (MVK) gene and identification of novel mutations causing mevalonic aciduria and hyperimmunoglobulinaemia D and periodic fever syndrome. Eur J Hum Genet 2001;9:253\u20139.","journal-title":"Eur J Hum Genet"},{"key":"BFpr201396_CR22","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.taap.2005.09.005","volume":"213","author":"X Deng","year":"2006","unstructured":"Deng X, Yu Z, Funayama H, et al. Mutual augmentation of the induction of the histamine-forming enzyme, histidine decarboxylase, between alendronate and immuno-stimulants (IL-1, TNF, and LPS), and its prevention by clodronate. Toxicol Appl Pharmacol 2006;213:64\u201373.","journal-title":"Toxicol Appl Pharmacol"},{"key":"BFpr201396_CR23","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1365-2249.2005.02928.x","volume":"142","author":"C H\u00e4rtel","year":"2005","unstructured":"H\u00e4rtel C, Adam N, Strunk T, Temming P, M\u00fcller-Steinhardt M, Schultz C . Cytokine responses correlate differentially with age in infancy and early childhood. Clin Exp Immunol 2005;142:446\u201353.","journal-title":"Clin Exp Immunol"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/pr201396.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/pr201396","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/pr201396.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T09:01:12Z","timestamp":1715504472000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/pr201396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,12]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["BFpr201396"],"URL":"https:\/\/doi.org\/10.1038\/pr.2013.96","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,12]]},"assertion":[{"value":"11 July 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}